BREAST


We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer. 

CURRENT STATUS:
NOT YET OPEN 

Detailed eligibility criteria available here   

 

PARTICIPANTS REGISTERED:
PARTICIPANTS RANDOMISED:
      

COLON/RECTUM 


We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
NOT YET OPEN 

Detailed eligibility criteria available here 

 

PARTICIPANTS REGISTERED:
PARTICIPANTS RANDOMISED:

STOMACH/OESOPHAGUS 


We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
NOT YET OPEN 

Detailed eligibility criteria available here 

PARTICIPANTS REGISTERED:
PARTICIPANTS RANDOMISED:

PROSTATE


We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer. 

CURRENT STATUS:
NOT YET OPEN 

Detailed eligibility criteria available here    

                                              PARTICIPANTS REGISTERED:
PARTICIPANTS RANDOMISED:
        

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015, www.cancerresearchuk.org), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38, www.nihr.ac.uk) and the MRC Clinical Trials Unit at UCL.
© Add-Aspirin, MRC CTU at UCL